Virus News and Research

Latest Virus News and Research

SARS-CoV-2 Omicron breakthrough infections induce antibodies with cross-variant neutralization potential and recall memory B cells

SARS-CoV-2 Omicron breakthrough infections induce antibodies with cross-variant neutralization potential and recall memory B cells

5 Apr 2022
Pre-existing memory B cell dynamics during SARS-CoV-2 Omicron breakthrough infection

Pre-existing memory B cell dynamics during SARS-CoV-2 Omicron breakthrough infection

5 Apr 2022
Study investigates the local-mucosal susceptibility and innate immune response to Omicron compared to other variants

Study investigates the local-mucosal susceptibility and innate immune response to Omicron compared to other variants

5 Apr 2022
Study demonstrates cross-neutralization among SARS-CoV-2 Omicron sublineages

Study demonstrates cross-neutralization among SARS-CoV-2 Omicron sublineages

5 Apr 2022
“MixOmicron” SARS-CoV-2 recombinant evades variant screening

“MixOmicron” SARS-CoV-2 recombinant evades variant screening

5 Apr 2022
Study generates a picture of the myocardial transcriptional landscape of COVID-19

Study generates a picture of the myocardial transcriptional landscape of COVID-19

5 Apr 2022
Study detects SARS-CoV-2 BA.1/BA.2 recombinant in two epidemiologically linked cases

Study detects SARS-CoV-2 BA.1/BA.2 recombinant in two epidemiologically linked cases

5 Apr 2022
Direction and magnitude of predictors of all-cause mortality following hospitalization with influenza, RSV, or SARS-CoV-2

Direction and magnitude of predictors of all-cause mortality following hospitalization with influenza, RSV, or SARS-CoV-2

5 Apr 2022
Prior COVID vaccination induces a more robust antibody response to Omicron

Prior COVID vaccination induces a more robust antibody response to Omicron

5 Apr 2022
Study on the efficacy of a BNT162b2 booster dose in the elderly

Study on the efficacy of a BNT162b2 booster dose in the elderly

5 Apr 2022
Air surveillance of SARS-CoV-2 and other respiratory pathogens

Air surveillance of SARS-CoV-2 and other respiratory pathogens

4 Apr 2022
The SAVE initiative to monitor the impact of SARS-CoV-2 variants

The SAVE initiative to monitor the impact of SARS-CoV-2 variants

4 Apr 2022
BNT162b2 booster vaccine provides equal protection against BA.1 and BA.2

BNT162b2 booster vaccine provides equal protection against BA.1 and BA.2

4 Apr 2022
Animal study provides insights into how COVID-19 can lead to long-term pain

Animal study provides insights into how COVID-19 can lead to long-term pain

4 Apr 2022
Study investigates targeted phenotyping of host proteins aiding drug repurposing in COVID-19

Study investigates targeted phenotyping of host proteins aiding drug repurposing in COVID-19

4 Apr 2022
SARS-CoV-2 prevalence during the initial period of SARS-CoV-2 Omicron variant emergence in Finland

SARS-CoV-2 prevalence during the initial period of SARS-CoV-2 Omicron variant emergence in Finland

4 Apr 2022
Travel in the time of covid: Getting there is easy — It’s getting home that’s hard

Travel in the time of covid: Getting there is easy — It’s getting home that’s hard

4 Apr 2022
Acute respiratory distress syndrome may increase death risk among young COVID-19 patients

Acute respiratory distress syndrome may increase death risk among young COVID-19 patients

4 Apr 2022
Case study of multi-system inflammatory syndrome in children in a fully vaccinated teenager

Case study of multi-system inflammatory syndrome in children in a fully vaccinated teenager

4 Apr 2022
Evidence SARS-CoV-2 undergoes ADAR-mediated A-to-I RNA editing in human cells

Evidence SARS-CoV-2 undergoes ADAR-mediated A-to-I RNA editing in human cells

4 Apr 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback